Isabella Margaret Davidson

Isabella Margaret Davidson

Auto-generated profile, based on publicly available information

Isabella Margaret Davidson

Health Sciences & Medicine Bond University Gold Coast Australia

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 October 2024 in Journal of Assisted Reproduction and Genetics
Verified
Journal Article
Open access
PDF file
IDI. M. Davidson
I. M. Davidson
ENE. Nikbakht
E. Nikbakht
Larisa M. HauptLarisa M. Haupt
Larisa M. Haupt
KAKevin Ashton
Kevin Ashton
PDP. J. Dunn
P. J. Dunn
Background: The female genital tract microbiome has become a particular area of interest in improving assisted reproductive technology (ART) outcomes with the emergence of next-generation sequencing (NGS) technology. However, NGS assessment of microbiomes currently lacks uniformity and poses significant challenges for accurate and precise bacterial population representation. Objective: As multiple NGS platforms and assays have been developed in recent years for microbiome investigation—including the advent of long-read sequencing technologies—this work aimed to identify current trends and practices undertaken in female genital tract microbiome investigations. Results: Areas like sample collection and transport, DNA extraction, 16S amplification vs. metagenomics, NGS library preparation, and bioinformatic analysis demonstrated a detrimental lack of uniformity. The lack of uniformity present is a significant limitation characterised by gap discrepancies in generation and interpretation of results. Minimal consistency was observed in primer design, DNA extraction techniques, sample transport, and bioinformatic analyses. Conclusion: With third-generation sequencing technology highlighted as a promising tool in microbiota-based research via full-length 16S rRNA sequencing, there is a desperate need for future studies to investigate and optimise methodological approaches of the genital tract microbiome to ensure better uniformity of methods and results interpretation to improve clinical impact. Graphical

29 May 2025 in Journal of Assisted Reproduction and Genetics
Verified
Journal Article
Open access
PDF file
IDIsabella M. Davidson
Isabella M. Davidson
ENElham Nikbakht
Elham Nikbakht
Larisa M. HauptLarisa M. Haupt
Larisa M. Haupt
PDPaul J. Dunn
Paul J. Dunn
Purpose: Rising demand for assisted reproductive technologies (ART) with limited improvements in success rates has driven interest in the impact of the vaginal microbiome on fertility outcomes. In order to fully examine the relationship between the vaginal microbiome and fertility outcomes, methodologies and technological developments must be standardised and benchmarked to provide the most accurate assessment of microbial population representation. Methods: This study sought to investigate the utility of 16S sequencing and bioinformatic approaches using nanopore sequencing to characterize core vaginal microbiota in a healthy Australian cohort of reproductive-age women. Results: Optimisation and comparison of different PCR strategies for whole 16S amplification was undertaken, along with the generation of bioinformatic analysis strategies. Initial qPCR identified the 27F-YM (MIX) primer as the most sensitive for C. trachomatis. However, nanopore sequencing revealed no detectable C. trachomatis across all six samples. Among the bioinformatic tools, Porechop with NanoCLUST most accurately identified microbial presence. Community state type (CST) I—characterised by Lactobacillus crispatus dominance—was identified as the most common CST (66%), aligning with patterns of a healthy vaginal microbiome. Conclusion: The findings highlight a Lactobacillus-rich microbiome as the most common among healthy females; however, further refinement—potentially through a metagenomics approach—is recommended to address 16S rRNA primer limitations to enable improved accuracy of microbial detection for the vaginal microbiome. Graphical

29 March 2026 in Microbial Ecology
Verified
Journal Article
Open access
PDF file
IDIsabella M. Davidson
Isabella M. Davidson
ENElham Nikbakht
Elham Nikbakht
HOHayley O'Neill
Hayley O'Neill
Larisa M. HauptLarisa M. Haupt
Larisa M. Haupt
PDPaul Joseph Dunn
Paul Joseph Dunn
The female microbiome, spanning the vaginal, gut, oral, and skin sites, harbours distinct microbial communities. Although the diversity and function of microbial communities across these sites are becoming increasingly understood, the extent to which modifiable lifestyle and environmental factors such as smoking, diet, alcohol intake, obesity, physical activity, stress, hygiene, and sexual behaviours shape these microbiomes remains underexplored. This review is restricted to modifiable lifestyle and environmental factors and does not comprehensively assess pharmaceutical exposures (e.g., antibiotics or hormonal therapies) or hormonal influence. To date, no review has comprehensively assessed and compiled evidence across the four microbial sites in females, despite their unique hormonal, physiological, and reproductive characteristics that distinctly influence microbial composition and function. This review provides a comprehensive examination of how such factors influence the dynamics of microbial composition and function along with site-specificity while also assessing cross-site microbial interactions. We focus exclusively on females to address a critical knowledge gap to provide a foundation from which future research and interventions can be tailored to women’s health. This review discusses the underlying mechanisms driving microbial shifts and their impact on host health, highlighting critical gaps in our current knowledge. The integration of findings from multi-site microbiome research, highlights the potential to inform targeted, preventative, and therapeutic strategies that utilise the inherent dynamic nature of the microbiome to improve health outcomes across the female lifespan.

22 October 2026 in The FEBS Journal
Verified
Journal Article
Open access
IDIsabella Margaret Davidson
Isabella Margaret Davidson
ENElham Nikbakht
Elham Nikbakht
HOHayley O'Neill
Hayley O'Neill
Larisa M. HauptLarisa M. Haupt
Larisa M. Haupt
PDPaul Joseph Dunn
Paul Joseph Dunn
The female microbiome is a complex, dynamic and site‐specific ecosystem that plays a vital role in maintaining host health, influencing immune regulation, metabolism, reproductive function and dermatological health. While significant attention has been directed towards modifiable lifestyle and environmental influences, host genetics, including inherited genetic variants in immune, cell signalling, metabolic, hormonal pathways and epithelial structure/barrier integrity, are increasingly recognised as contributors to microbial composition across distinct anatomical niches in individuals. It is theorised that these factors influence core microbial communities, predisposing individuals to dysbiosis or enhanced resilience against potential pathogens. This review integrates current evidence on how host genetics shape the female vaginal, gut, oral and skin microbiomes. By evaluating these influences across body sites, critical research gaps limiting our understanding of inherited microbe–host interactions and their contribution to disease susceptibility and persistence are identified. Addressing these gaps is essential for advancing insights into microbial composition and for informing personalised health strategies to identify populations contributing to greater risk of microbiome‐associated negative health outcomes.